Pineal Melatonin Functions and the Depression of Parkinson's Disease: A Hypothesis

References

• Agid Y., Javoy-Agid F. Peptides and Parkinson's disease. Trends in Neurosciences 1985; 8: 30–35
   Web of Science ®Google Scholar
• Aldegunde M., Miquez I., Veira J. Effects of pinealectomy on reginal brain serotinin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Anton-Tay F. Melatonin: Effects of brain function. Advances in biochemical psychopharmacology, E. Costa, G. L. Gessa, M. Sandler. Raven Press, New York 1974; 315–324
   Google Scholar
• Anto-Tay F., Chou C., Anton S., Wurtman R. J. Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–278
   PubMed Web of Science ®Google Scholar
• Brown R., Kocsis J. H., Caroff S., Amsterdam J., Winokur A., Stokes P. E., Frazer A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. American Journal of Psychiatry 1985; 142: 811–816
   PubMed Web of Science ®Google Scholar
• Chase T. N. Serotonergic mechanisms in Parkinson's disease. Neurology 1972; 27: 354–356
   Web of Science ®Google Scholar
• Dray A. Serotonin in the basal ganglia: functions and interactions with other neuronal pathways. Journal of Physiology, (Paris) 1981; 77: 393–403
   PubMedGoogle Scholar
• Erlich S. S., Apuzzo M. L.J. The pineal gland: anatomy, physiology, and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Escourolle R., de Recondo J., Gray F. Etude anatomopathologique des syndrome parkinsoniens. Monoamines, Noyaux Gris Centraux et Sydrome de Pardinson, J. Ajuriaguerra, J. Gauthier. Masson, Paris 1970; 173–229
   Google Scholar
• Goetz C. G., Luthe W., Tanner C. M. Autonomic dysfunction in Parkinson's disease. Neurology 1986; 36: 73–75
   PubMed Web of Science ®Google Scholar
• Iguchi H., Kato H., Ibayashi H. Age-dependent reduction in serum melatonin concentrations in healthy human subjects. Journal of Clinical Endocrinology & Metabolism 1982; 55: 27–29
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Viosca S., Nair R. M.G., Schally A. V., Miller M. C. Interactions between pineal, hypothalamus and pituitary involving melatonin, MSH release inhibiting factor and MSH. Endocrinology 1972; 91: 1323–1328
   PubMed Web of Science ®Google Scholar
• Kavaliers M., Hirst M., Teskey G. C. Ageing, opioid analgesia and the pineal gland. Life Sciences 1983; 32: 2279–2287
   PubMed Web of Science ®Google Scholar
• Klein D. C. The pineal gland: A model of neuroendocrine regulation. The hypothalamus, S. Reichlin, R. J. Baldessarini, J. B. Martin. Raven Press, New York 1987; 303–327
   Google Scholar
• Kostic V. S., Djuricic B. M., Covickovic-Sternic N. M., Mrsulja B. B. Depression and Parkinson's disease: possible role of serotonergic mechanisms. Journal of Neurology 1987; 234: 94–96
   PubMed Web of Science ®Google Scholar
• Kumar M. S. A., Besch E. L., Millard W. J., Sharp D. C., Leadem C. A. Effect of short photoperiod on hypothalamic methionine-enkephalin and LHRH content and serum beta-endorphinlike immunoreactivity (beta-end LI) levels in golden hamsters. Journal of Pineal Research 1984; 1: 197–205
   PubMed Web of Science ®Google Scholar
• Lakin M. L., Miller C. H., Statt M. I., Winters W. D. Involvement of the pineal gland and melatonin in murine analgesia. Life Sciences 1981; 29: 2543–2551
   PubMed Web of Science ®Google Scholar
• Langston J. W., Forno L. S. The hypothalamus in Parkinson's disease. Annals of Neurology 1978; 3: 129–133
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Nurenberger J. I., Wehr T. A., Pack D., Becker L. E., Powell R. L., Newsone D. A. Supersensitivity to light: possible trait marker for manic-depressive illness. American Journal of Psychiatry 1985; 142: 725–727
   PubMed Web of Science ®Google Scholar
• Mayeux R. Mental State. Handbook of Parkinson's disease, W. C. Koller. Marcel Dekker, New York 1987; 127–144
   Google Scholar
• Mayeux R., Stern Y., Rosen J., Leventhal J. Depression, intellectual impairment and Parkinson's disease. Neurology 1981; 31: 645–650
   PubMed Web of Science ®Google Scholar
• Mayeux R., Stern Y., Williams J. B. W., Cote L., Frantz A., Dyrenfurth I. Clinical and biochemical features of depression in Parkinson's disease. American Journal of Psychiatry 1986; 143: 756–759
   PubMed Web of Science ®Google Scholar
• Mayeux R., Stern Y., Williams J. B. W., Cote L. J. The relationship of serotonin to depression in Parkinson's disease. Movement Disorders 1988; 3: 237–244
   PubMed Web of Science ®Google Scholar
• Mayeux R., Stern Y., Cote L., Williams J. B. W. Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 1984; 5: 642–648
   Google Scholar
• Mindham R. H. S. Psychiatric symptoms in parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry 1970; 33: 188–189
   PubMed Web of Science ®Google Scholar
• Namboodiri M. A. A., Sugden D., Klein D. C., Mefford I. N. 5-hydroxytryptophan elevates serum melatonin. Science 1983; 221: 659–660
   PubMed Web of Science ®Google Scholar
• Nappi G., Petraglia F., Martignoni E. Beta-endorphin cerebrospinal fluid decrease in untreated parkinsonian patients. Neurology 1985; 35: 1371–1374
   PubMed Web of Science ®Google Scholar
• Ohama E., Ikuta F. Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system. Acta Neuropathologica (Berlin) 1976; 34: 311–319
   PubMed Web of Science ®Google Scholar
• Pique L., Jegou S., Bertagna X., Javoy-Agid F., Seurin D., Proeschel M. F., Girard F., Agid Y., Vaudry H., Lutton J. P. Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients. Neuroscience Letters 1985; 54: 141–146
   PubMed Web of Science ®Google Scholar
• Rainero I., Pinessi L. alpha-MSH and Parkinson disease. Italian Journal of Neurological Sciences 1988; 9: 95–96, 1988
   PubMedGoogle Scholar
• Rinne U. K., Rinne J. K., Laakso K., Tenovuo O., Lonnberg P., Koskinen V. Brain enkephalin receptors in Parkinson's disease. Journal of Neural Transmission 1983; 19: 163–171
   Google Scholar
• Sack R. L., Lewy A. J., Erb D. L., Vollmer W. M., Singer C. M. Human melatonin productin decreases with age. Journal of Pineal Research 1988; 3: 379–388
   Web of Science ®Google Scholar
• Sandyk R., Fisher H. Serotonin in involuntary movement disorders. International Journal of Neuroscience 1988; 42: 185–205
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P., Bamford C. R. The hypothalamus in Parkinson disease. Italian Journal of Neurological Sciences 1987; 8: 227–234
   PubMedGoogle Scholar
• Sandyk R., Mukherjee S. Attenuation of reserpine-induced catalepsy in melatonin and the role of the opioid system. International Journal of Neuroscience, (in press)
   Web of Science ®Google Scholar
• Sano V. I., Taniguchi K. L-5-hydroxytryptophan (L-5-HTP) Therapie des morbus Parkinson. Munschner Medizinische Wochenschrift 1972; 114: 1717–1719
   PubMedGoogle Scholar
• Santamaria J., Tolosa E., Valles A. Parksinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 1986; 36: 1130–1133
   PubMed Web of Science ®Google Scholar
• Sawada M., Nagatsu I., Ito K., Iizuka R., Kondo T., Barabayashi H. Tryptophan hydroxylase activity in the brains of controls and parkinsonian patients. Journal of Neural Transmission 1985; 62: 107–115
   PubMed Web of Science ®Google Scholar
• Shaw K. M., Stern G. M., Sandler M. Melatonin and parkinsonism. Lancet 1973; 2: 271
   Google Scholar
• Souetre E., Salvati E., Belugou J. L., Robert P., Brunet G., Darcourt G. Antidepressant effect of 5-methoxypsoralen: a preliminary report. Psychopharmacology 1988; 95: 430–431
   PubMed Web of Science ®Google Scholar
• Tetsuo M., Polisky R. J., Markey S. P., Kopin I. J. Urinary 6-hydroxymelatonin excretion in patients with orthostatic hypotension. Journal of Clinical Endocrinology & Metabolism 1982; 53: 607–610
   Web of Science ®Google Scholar